Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pelthos Therapeutics (PTHS) Shares Issued (2024 - 2025)

Pelthos Therapeutics has reported Shares Issued over the past 2 years, most recently at $121000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $121000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $121000.0 (down 97.97% YoY), and the annual figure for FY2025 was $206000.0, down 96.55%.
  • Shares Issued for Q4 2025 was $121000.0 at Pelthos Therapeutics, down from $6.0 million in the prior quarter.
  • Over the last five years, Shares Issued for PTHS hit a ceiling of $6.0 million in Q1 2024 and a floor of $121000.0 in Q4 2025.